Keppra 500mg Tablet contains Levetiracetam, an anticonvulsant medication primarily indicated for the treatment of epilepsy. It is used as adjunctive therapy in the management of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal excitability. Keppra is well-absorbed orally, with rapid onset of action and minimal hepatic metabolism, reducing the potential for drug interactions. The 500mg dosage form allows for flexible titration based on clinical response and tolerability. Common adverse effects include somnolence, dizziness, headache, and fatigue, which are generally mild to moderate in intensity. Serious side effects are rare but may include behavioral changes or hypersensitivity reactions. Keppra should be used with caution in patients with renal impairment, and dose adjustments may be necessary. Regular monitoring of seizure control and side effects is recommended to optimize therapy. Keppra 500mg Tablet offers an effective and well-tolerated option for seizure management, improving patient quality of life through enhanced seizure control.